The blood-brain barrier might be harmed in a diabetes-induced inflammatory environment under the influence of elevated interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α levels, and advanced glycation end products (AGEs) accumulation (Yang et al., 2024). The gene discussed is TNF; the disease is diabetes mellitus.